scholarly article | Q13442814 |
P50 | author | Sheena Sullivan | Q47162612 |
James E Fielding | Q56810082 | ||
Heath A. Kelly | Q117653221 | ||
Kristina A. Grant | Q117688818 | ||
P2860 | cites work | Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study | Q21144621 |
I-MOVE multi-centre case control study 2010-11: overall and stratified estimates of influenza vaccine effectiveness in Europe | Q28742719 | ||
Working towards a simple case definition for influenza surveillance. | Q30333094 | ||
Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. | Q30357784 | ||
Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. | Q30379529 | ||
Influenza A (H1N1) in Victoria, Australia: a community case series and analysis of household transmission | Q30396017 | ||
Pandemic influenza H1N1 2009 infection in Victoria, Australia: no evidence for harm or benefit following receipt of seasonal influenza vaccine in 2009. | Q30401633 | ||
Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010 | Q30404923 | ||
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis | Q30408691 | ||
Vaccine effectiveness in preventing influenza hospitalizations in Navarre, Spain, 2010-2011: cohort and case-control study | Q30409727 | ||
Effectiveness of the 2010-11 seasonal trivalent influenza vaccine in Spain: cycEVA study | Q30414952 | ||
Estimation of influenza vaccine effectiveness from routine surveillance data | Q33424462 | ||
The impact of matching vaccine strains and post-SARS public health efforts on reducing influenza-associated mortality among the elderly | Q33622358 | ||
Estimation of type- and subtype-specific influenza vaccine effectiveness in Victoria, Australia using a test negative case control method, 2007-2008 | Q33931144 | ||
Time lines of infection and disease in human influenza: a review of volunteer challenge studies | Q34743132 | ||
Efficacy studies of influenza vaccines: effect of end points used and characteristics of vaccine failures | Q34754945 | ||
Moderate influenza vaccine effectiveness in Victoria, Australia, 2011. | Q40027900 | ||
Laboratory diagnosis and surveillance of human respiratory viruses by PCR in Victoria, Australia, 2002-2003. | Q40521075 | ||
Antigenic characterisation of influenza B virus with a new microneutralisation assay: comparison to haemagglutination and sequence analysis | Q45613090 | ||
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results | Q45848424 | ||
Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season | Q46159620 | ||
A sentinel platform to evaluate influenza vaccine effectiveness and new variant circulation, Canada 2010-2011 season | Q47843797 | ||
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. | Q50801938 | ||
Epidemiological, antigenic and genetic characteristics of seasonal influenza A(H1N1), A(H3N2) and B influenza viruses: Basis for the WHO recommendation on the composition of influenza vaccines for use in the 2009–2010 Northern Hemisphere season | Q57193627 | ||
Effectiveness of H1N1/09 monovalent and trivalent influenza vaccines against hospitalization with laboratory-confirmed H1N1/09 influenza in Australia: A test-negative case control study | Q57210380 | ||
Large trials confirm immunogenicity of H1N1 vaccines | Q59157377 | ||
P433 | issue | 5 | |
P921 | main subject | vaccine | Q134808 |
influenza vaccine | Q383260 | ||
P304 | page(s) | 729-737 | |
P577 | publication date | 2012-10-19 | |
P1433 | published in | Influenza and Other Respiratory Viruses | Q15765099 |
P1476 | title | Moderate influenza vaccine effectiveness with variable effectiveness by match between circulating and vaccine strains in Australian adults aged 20-64 years, 2007-2011. | |
P478 | volume | 7 |
Q33779681 | 2012-2013 Seasonal influenza vaccine effectiveness against influenza hospitalizations: results from the global influenza hospital surveillance network |
Q36748191 | Assessment of potential public health impact of a quadrivalent inactivated influenza vaccine in Thailand |
Q46969068 | Both hemispheric influenza vaccine recommendations would have missed near half of the circulating viruses in Madagascar |
Q34783486 | Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis |
Q98889330 | Comparison of immunogenicity between candidate influenza A(H3N2) virus vaccine strains in Japan: A randomized controlled trial using a monovalent vaccine of A/Saitama/103/2014 (CEXP-002) and A/Hong Kong/4801/2014 (X-263) |
Q35091073 | Comparison of the epidemiology of laboratory-confirmed influenza A and influenza B cases in Manitoba, Canada |
Q30403059 | Effect of previous and current vaccination against influenza A(H1N1)pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain |
Q31161295 | Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies |
Q42374407 | Emergency Department demand associated with seasonal influenza, 2010 through 2014, New South Wales, Australia. |
Q37638402 | Epidemiology of influenza B in Australia: 2001-2014 influenza seasons |
Q37370619 | Epidemiology of the 2012 influenza season in Victoria, Australia |
Q33756162 | First-year results of the Global Influenza Hospital Surveillance Network: 2012-2013 Northern hemisphere influenza season |
Q37643313 | Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial |
Q28469374 | Influenza Vaccine Effectiveness in the Netherlands from 2003/2004 through 2013/2014: The Importance of Circulating Influenza Virus Types and Subtypes |
Q42244861 | Influenza vaccine effectiveness during the 2012 influenza season in Victoria, Australia: influences of waning immunity and vaccine match |
Q35743969 | Influenza vaccine effectiveness in the tropics: moderate protection in a case test-negative analysis of a hospital-based surveillance population in Bangkok between August 2009 and January 2013 |
Q38415770 | Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season |
Q47413448 | Low influenza vaccine effectiveness and the effect of previous vaccination in preventing admission with A(H1N1)pdm09 or B/Victoria-Lineage in patients 60 years old or older during the 2015/2016 influenza season. |
Q90108074 | Modelling of optimal timing for influenza vaccination as a function of intraseasonal waning of immunity and vaccine coverage |
Q36090140 | Prediction of influenza B vaccine effectiveness from sequence data |
Q36317045 | Quantifying Protection Against Influenza Virus Infection Measured by Hemagglutination-inhibition Assays in Vaccine Trials |
Q42283556 | Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012. |
Q30383722 | Seasonal influenza vaccine effectiveness estimates: Development of a parsimonious case test negative model using a causal approach |
Q90692852 | The Use of Test-negative Controls to Monitor Vaccine Effectiveness: A Systematic Review of Methodology |
Q36207731 | The effectiveness of seasonal trivalent inactivated influenza vaccine in preventing laboratory confirmed influenza hospitalisations in Auckland, New Zealand in 2012 |
Q38275284 | Understanding influenza vaccine protection in the community: an assessment of the 2013 influenza season in Victoria, Australia |
Q24197955 | Vaccines for preventing influenza in healthy adults |
Q56603717 | Vaccines for preventing influenza in healthy adults |